Atlas Trials

EPA Supplementation on Vascular Inflammation, and Gene Expression of PON2 in Patients With Type II Diabetes Mellitus

Clinical trial NCT03258840 · COMPLETED

Trial details

NCT number
NCT03258840
Sponsor
Tehran University of Medical Sciences
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes Mellitus Type II
Start date
2013-01-01
Primary completion
2013-04-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.